Sorrento Therapeutics (SRNEQ)
OTHER OTC:SRNEQ

Sorrento Therapeutics (SRNEQ) Stock Investors

5,263 Followers
Based on 688,082 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

0.2% of all portfolios hold SRNEQ
On average, investors allocate 2.27% of their portfolios to SRNEQ
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding SRNEQ

0.9%
Last 7
Days
6.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding SRNEQ, out of 688,082 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

SRNEQ Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
0.03%
$0.21
Opened
0.36%
$0.34
Increased
<0.01%
$2.15
Based on the activity of 12,728 investors who made their portfolios public
The table shows changes in SRNEQ in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

SRNEQ Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Moderna
5.06%
-0.05%
+0.36%
37.34B
Healthcare
Nikola
6.40%
-0.42%
-1.06%
1.28B
Energy
Micron
5.65%
-0.63%
-2.38%
74.41B
Technology
Coherus Biosciences
2.49%
-1.23%
+814.97%
439.70M
Healthcare
Roku
5.12%
-0.59%
-2.44%
8.42B
Technology
Blink Charging Co
4.21%
-0.31%
+1.49%
190.61M
Utilities
Block
4.20%
+0.09%
+0.14%
24.62B
Technology
AMC Entertainment
5.28%
-0.09%
+0.41%
1.57B
Consumer Cyclical
Assertio Therapeutics
3.14%
-1.25%
-6.03%
240.22M
Healthcare
Marvell
4.80%
-0.14%
+1.47%
44.62B
Technology
Based on the activity of 688,082 active portfolios
Open your Smart Portfolio

SRNEQ Investor Analysis

SRNEQ investors under 35

Under 35

23.3%
Last 30 days
Holdings Change
13.0%
of SRNEQ holders
are under 35
Average Segment Performance
Average P/E Ratio-29.29
Beta9.51
Dividend Yield5.66%
SRNEQ investors between 35–55

Between 35–55

6.3%
Last 30 days
Holdings Change
56.3%
of SRNEQ holders
are between 35–55
Average Segment Performance
Average P/E Ratio-25.99
Beta14.43
Dividend Yield18.73%
SRNEQ investors over 55

Over 55

3.9%
Last 30 days
Holdings Change
30.6%
of SRNEQ holders
are over 55
Average Segment Performance
Average P/E Ratio-18.64
Beta5.43
Dividend Yield5.39%
Overview of age group and performance of SRNEQ stock investors
See who invests in SRNEQ according to age group and performance.

FAQ

How many retail Investors hold SRNEQ?
0.2% of TipRank’s retail investors hold SRNEQ in their portfolios.
    What is SRNEQ Investor Sentiment?
    SRNEQ’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of SRNEQ in the last 7 days?
      ▼ 0.9% of TipRank’s retail investors changed their holding of SRNEQ in the last 7 days.
        What percentage of retail investors changed their holding of SRNEQ in the last 30 days?
        ▼ 6.3% of TipRank’s retail investors changed their holding of SRNEQ in the last 30 days.
          What is the average age of retail investors who hold SRNEQ?
          The average age of SRNEQ Holders is between 35–55.
            What other stocks have SRNEQ investors also bought?
            SRNEQ Investors also bought MRNA, NKLA, MU, CHRS, ROKU, BLNK, SQ, AMC, ASRT, MRVL.

              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              CORCencora
              BSXBoston Scientific
              CNCCentene
              CHRSCoherus Biosciences

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis